The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

India's largest pharma IPO set to hit market

India's largest pharma IPO set to hit market
India's largest pharma IPO set to hit market
The company posted revenue of Rs 2,772 crore for the year ended March 2020 as against Rs 2,129.7 crore in the previous year.

Synopsis

This will be the largest IPO by a pharmaceutical company in India. The biggest IPO till date in the sector was from Eris Lifesciences, which raised Rs 1,741 crore in 2017. Alkem Laboratories and Laurus Labs raised Rs 1,350 crore each in 2015 and 2016, respectively.

Mumbai: Hyderabad-based Gland Pharma’s Rs 6,000 crore initial public offer (IPO) is set to hit the market next week, according to bankers.This will be the largest IPO by a pharmaceutical company in India. The biggest IPO till date in the sector was from Eris Lifesciences, which raised Rs 1,741 crore in 2017. Alkem Laboratories and Laurus Labs raised Rs 1,350 crore each in 2015 and 2016, respectively. So far, only 14 Indian companies have raised
Share This Article
  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • COMMENT

To Read the Full Story, Become an ET Prime Member

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Access the exclusive Economic Times stories, Editorial and Expert opinion

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise
The Economic Times